Diabetogenic Action of GH and Cortisol in Insulin-Dependent Diabetes Mellitus Aspects of the Mechanisms Behind the Somogyi Phenomenon

Summary

The effect on glucose homeostasis of a transient elevation of plasma growth hormone (GH) and cortisol was studied over 6 h in 14 male patients with insulin-dependent diabetes mellitus (IDDM) by using an i. v. somatostatin (100 μg/h) - insulin (0.4 mU/kg/min) glucose (3 mg/kg/min) - infusion test (SIGIT). GH (20 mU/kg) was given as a 60 min i. v. infusion during the initial SIGIT period raising the plasma GH level to about 40 jug/I, and returning to low basal within 3 h. ACTH (0.1 mg) was given as an i. v. bolus injection at the start of the SIGIT, resulting in plasma cortisol peak values of about 900 nmol/l within 2-3 h. GH raised blood glucose after a lag of 4 h while ACTH alone had no effect. However, ACTH added to GH enhanced the diabetogenic effect of GH. It is concluded that an episodic increase in circulating GH-cortisol, resembling the responses of these hormones to an insulin-induced hypoglycemia, exerts a diabetogenic effect in IDDM-patients not deprived of insulin. While GH is essential in this respect the diabetogenic effect of cortisol is evident only in conjunction with GH.

Key-Words

Diabetes Mellitus - Counter-Regulatory Hormones - Growth Hormone - Cortisol - Insulin Resistance